Recommend Praxbind to Reverse Pradaxa In Patients With Life-Threatening Bleeding

December 2015

Praxbind (PRAKS-bynd, idarucizumab) will be the first reversal agent for ONE of the direct oral anticoagulants.

We know that vitamin K reverses bleeding due to warfarin...but not direct oral anticoagulants. So managing bleeding with these has been limited to stopping the drug, supportive care, using blood products, etc.

Praxbind is an IV monoclonal antibody fragment that binds to the thrombin inhibitor, Pradaxa (dabigatran), to reverse anticoagulation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote